ClinicalTrials.Veeva

Menu

Study of the Clinical Efficacy of Autologous SCT in Patients With Critical Limb Ischemia

K

King Faisal Specialist Hospital & Research Center

Status

Unknown

Conditions

Critical Limb Ischemia

Treatments

Procedure: SCT

Study type

Observational

Funder types

Other

Identifiers

NCT01311011
RAC# 2081-026

Details and patient eligibility

About

Phase II Prospective Study of the Clinical Efficacy of Autologous SCT in patients with Critical Limb Ischemia

Full description

Phase II Prospective Study of the Clinical Efficacy of Autologous SCT in patients with Critical Limb Ischemia

Enrollment

26 estimated patients

Sex

All

Ages

14 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with Critical Limb Ischemia

Exclusion criteria

  • Patients with other than Critical Limb Ischemia

Trial contacts and locations

1

Loading...

Central trial contact

H Al-Zahrani, M.D.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems